Prevention and management of RhD isoimmunization

Clinics in Perinatology

Volumn 31, Issue 4, 2004, Pages 721-742

  Harkness, Ursula F ^a   Spinnato, Joseph A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

AMNION FLUID; AMNION FLUID ANALYSIS; ANTIGEN EXPRESSION; DOPPLER ECHOGRAPHY; FOLLOW UP; HEMOLYTIC ANEMIA; HUMAN; MIDDLE CEREBRAL ARTERY; OUTCOMES RESEARCH; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RHESUS ISOIMMUNIZATION; RISK ASSESSMENT; RISK FACTOR; SPECTROSCOPY; SYSTOLIC BLOOD PRESSURE;

EID: 7044264997     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2004.06.005     Document Type: Review

References (79)

1. J.M. Bowman Hemolytic disease (erythroblastosis fetalis) R.K. Creasy R. Resnik Maternal-fetal medicine 4th edition 1999 WB Saunders Philadelphia 736 767
2. K.J. Moise Jr Management of Rhesus alloimmunization in pregnancy Obstet Gynecol 100 2002 600 611
3. V.J. Freda Recent advances in the Rh problem Trans N Engl Obstet Gynecol Soc 18 1964 91 104
4. J.M. Bowman Controversies in Rh prophylaxis: who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol 151 1985 289 294
5. G.F. Chavez, J. Mulinare, and L.D. Edmonds Epidemiology of Rh hemolytic disease of the newborn in the United States JAMA 265 1991 3270 3274
6. O. Geifman-Holtzman, M. Wojtowycz, E. Kosmas, and R. Artal Female alloimmunization with antibodies known to cause hemolytic disease Obstet Gynecol 89 1997 272 275
7. American College of Obstetricians and Gynecologists Prevention of RhD alloimmunization. ACOG Practice Bulletin no. 4 1999 American College of Obstetricians and Gynecologists Washington, DC
8. K.L. Moore, and T.V.N. Persaud Before we are born: essentials of embryology and birth defects 4th edition 1993 WB Saunders Philadelphia
9. H. Bergstrom, L.A. Nilson, L. Nisson, and L. Ruttinger Demonstration of Rh antigens in a 38-day-old fetus Am J Obstet Gynecol 99 1967 130 133
10. A. Zipursky, J. Pollack, P. Neelands, B. Chown, and L.G. Israels The transplacental passage of foetal red blood cells and the pathogenesis of Rh immunization during pregnancy Lancet 35 1963 489 493
11. G.A. Von Stein, R.A. Munsick, K. Stiver, and K. Ryder Fetomaternal hemorrhage in threatened abortion Obstet Gynecol 79 1992 383 386
12. M. Leong, S. Duby, and R. Kinch Fetal-maternal transfusion following early abortion Obstet Gynecol 54 1979 424 426
13. H.L. Howard, V.J. Martlew, I.R. McFadyen, and C.A. Clarke Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed? Br J Obstet Gynaecol 104 1997 37 41
14. V.D. Dayton, D.S. Anderson, J.T. Crosson, and S.H. Cruikshank A case of Rh isoimmunization: should threatened first-trimester abortion be an indication for Rh immune globulin prophylaxis? Am J Obstet Gynecol 163 1990 63 64
15. R.D. Visscher, and H.C. Visscher Do Rh-negative women with an early spontaneous abortion need Rh immune prophylaxis? Am J Obstet Gynecol 113 1972 158 162
16. J. Bowman Thirty-five years of Rh prophylaxis Transfusion 43 2003 1661 1666
17. S.C. Robson, D. Lee, and S. Urbaniak Anti-D immunoglobulin in RhD prophylaxis Br J Obstet Gynaecol 105 1998 129 134
18. H.E. Beveridge Dwindling supplies of anti-D Med J Aust 167 1997 509 510
19. V.J. Freda, J.G. Gorman, W. Pollack, and E. Bowe Prevention of Rh hemolytic diseaseâ€"ten years' clinical experience with Rh immune globulin N Engl J Med 292 1975 1014 1016
20. W. Pollack, Q. Ascari, R.J. Kochesky, R.R. O'Connor, T.Y. Ho, and D. Tripodi Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus Transfusion 11 1971 333 339
21. J.M. Bowman, B. Chown, M. Lewis, and J.M. Pollack Rh isoimmunization during pregnancy: antenatal prophylaxis Can Med Assoc J 118 1978 623 627
22. J.M. Bowman, and J.M. Pollack Antenatal prophylaxis of Rh isoimmunization: 28-weeks'-gestation service program Can Med Assoc J 118 1978 6127 6130
23. E.L. Snyder, and K.S. Lipton Prevention of hemolytic disease of the newborn due to anti-D. Prenatal/perinatal testing and Rh immune globulin administration American Association of Blood Banks Association Bulletin 98 1998 1 6
24. P.M. Ness, M.L. Baldwin, and J.R. Niebyl Clinical high-risk designation does not predict excess fetal-maternal hemorrhage Am J Obstet Gynecol 156 1987 154 158
25. C.M. Stedman, J.C. Baudin, C.A. White, and E.S. Cooper Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women Am J Obstet Gynecol 154 1986 1363 1369
26. K.J. Blakemore, A. Baumgarten, M. Schoenfeld-Dimaio, J.C. Hobbins, E.A. Mason, and M.J. Mahoney Rise in maternal serum α-fetoprotein concentration after chorionic villus sampling and the possibility of isoimmunization Am J Obstet Gynecol 155 1986 988 993
27. M.A. Blajchman, R.F. Maudsley, I. Uchida, and A. Zipursky Diagnostic amniocentesis and fetal-maternal bleeding Lancet 1 7864 1974 993 994
28. J.R. Price Rh sensitization by hydatidiform mole N Engl J Med 278 1968 1021
29. R.G. Marcus, H. Crewe-Brown, S. Krawitz, and J. Katz Feto-maternal haemorrhage following successful and unsuccessful attempts at external cephalic version Br J Obstet Gynaecol 82 1975 578 580
30. T.K. Lau, A. Stock, and M. Rogers Fetomaternal haemorrhage after external cephalic version at term Aust N Z J Obstet Gynaecol 35 1995 173 174
31. U. Nicolini, N.K. Kochenour, P. Greco, E. Letsky, M. Contreras, and C.H. Rodeck Consequences of fetomaternal hemorrhage after intrauterine transfusion BMJ 297 1988 1379 1381
32. K.D. Balderston, C.V. Towers, P.J. Rumney, and D. Montgomery Is the incidence of fetal-to-maternal hemorrhage increased in patients with third-trimester bleeding? Am J Obstet Gynecol 188 2003 1615 1621
33. B. Brambati, S. Guercilena, I. Bonacchi, A. Oldrini, A. Lanzani, and L. Piceni Feto-maternal transfusion after chorionic villus sampling: clinical implications Hum Reprod 1 1986 37 40
34. K. Fung Kee Fung, E. Eason, J. Crane, A. Armson, S. De La Ronde, and D. Farine Maternal-Fetal Medicine Committee. Genetics Committee J Obstet Gynaecol Can 25 2003 716 719
35. M.L. Scott Monoclonal anti-D for immunoprophylaxis Vox Sang 81 2001 213 218
36. B.M. Kumpel In vivo studies of monoclonal anti-D and the mechanism of immune suppression Transfus Clin Biol 9 2002 9 14
37. M.H. Kanter Derivation of new mathematic formulas for determining whether a D-positive father is heterozygous or homozygous for the D antigen Am J Obstet Gynecol 166 1992 61 63
38. F.F. Wagner, and W.A. Flegel RhD gene deletion occurred in the Rhesus box Blood 95 2000 3662 3668
39. R.W.K. Chiu, M.F. Murphy, C. Fidler, B.C.Y. Zee, J.S. Wainscoat, and Y.M.D. Lo Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach Clin Chem 47 2001 667 672
40. P.R. Bennett, C. Le Van Kim, Y. Colin, R.M. Warwick, B. Cherif-Zahar, and N. Fisk Prenatal determination of fetal RhD type by DNA amplification N Engl J Med 329 1993 607 610
41. I.B. Van den Veyver, and K.J. Moise Jr Fetal RhD typing by polymerase chain reaction in pregnancies complicated by Rhesus alloimmunization Obstet Gynecol 88 1996 1061 1067
42. G.A. Dildy, G.M. Jackson, and K. Ward Determination of fetal RhD status from uncultured amniocytes Obstet Gynecol 88 1996 207 210
43. C. Cotorruela, C. Biondi, S. Garcia Borras, R. Di Monaco, and A. Racca Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn Clin Exp Med 2 2002 77 81
44. O. Geifman-Holtzman, I.M. Bernstein, S.M. Berry, E.J. Holtzman, T.J. Vadnais, and M.A. DeMaria Fetal RhD genotyping in fetal cells flow sorted from maternal blood Am J Obstet Gynecol 174 1996 818 822
45. Y.M.D. Lo, N.M. Hjelm, C. Fidler, I.L. Sargent, M.F. Murphy, and P.F. Chamberlain Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma N Engl J Med 339 1998 1734 1738
46. American College of Obstetricians and Gynecologists Management of isoimmunization in pregnancy. ACOG Educational Bulletin no. 227 1996 American College of Obstetricians and Gynecologists Washington, DC
47. J.A. Spinnato Hemolytic disease of the fetus: a plea for restraint Obstet Gynecol 80 1992 873 877
48. A.W. Liley Liquor amnii analysis in the management of pregnancy complicated by rhesus sensitization Am J Obstet Gynecol 82 1961 1359 1370
49. K.H. Nicolaides, C.H. Rodeck, R.S. Mibashan, and J.R. Kemp Have Liley charts outlived their usefulness? Am J Obstet Gynecol 155 1986 90 94
50. E. Sikkel, F.P.H.A. Vandenbussche, D. Oepkes, R.H. Meerman, S. Le Cessie, and H.H.H. Kanhai Amniotic fluid ΔOD 450 values accurately predict severe fetal anemia in D-alloimmunization Obstet Gynecol 100 2002 51 57
51. J.T. Queenan, T.P. Tomai, S.H. Ural, and J.C. King Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management Am J Obstet Gynecol 168 1993 1370 1376
52. J.A. Spinnato, A.L. Clark, K.K. Ralston, E.R. Greenwell, and L.J. Goldsmith Hemolytic disease of the fetus: a comparison of the Queenan and extended Liley methods Obstet Gynecol 92 1998 441 445
53. F. Scott, and F.Y. Chan Assessment of the clinical usefulness of the "Queenan" chart versus the "Liley" chart in predicting severity of Rhesus iso-immunization Prenat Diagn 18 1998 1143 1148
54. J.I. Vaughn, R. Warwick, E. Letsky, U. Nicolini, C.H. Rodeck, and N.M. Fisk Erythropoietic suppression in fetal anemia because of Kell alloimmunization Am J Obstet Gynecol 171 1994 247 252
55. D.S. McKenna, H.N. Nagaraja, and R. O'Shaughnessy Management of pregnancies complicated by anti-Kell isoimmunization Obstet Gynecol 93 1999 667 673
56. C.Y. Spong, A.E. Porter, and J.T. Queenan Management of isoimmunization in the presence of multiple maternal antibodies Am J Obstet Gynecol 185 2001 481 484
57. D.N. Hackney, E.J. Knudtson, K.Q. Rossi, D. Krugh, and R.W. O'Shaughnessy Management of pregnancies complicated by anti-c isoimmunization Obstet Gynecol 103 2004 24 30
58. F.C. Fan, R.Y.Z. Chen, G.B. Schuessler, and S. Chien Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog Am J Physiol 238 1980 H545 H552
59. G. Mari For the Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red cell alloimmunization N Engl J Med 342 2000 9 14
60. R. Zimmerman, P. Durig, R.J. Carpenter Jr, and G. Mari Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat BJOG 109 2002 746 752
61. J.M.A. Teixeira, K. Duncan, E. Letsky, and N.M. Fisk Middle cerebral artery peak systolic velocity in the prediction of fetal anemia Ultrasound Obstet Gynecol 15 2000 205 208
62. A. Baschat, M. Kush, C. Harman, and C. Weiner Hematologic indices and fetal oxygenation determine middle cerebral artery peak systolic velocity (MCA-PSV) Am J Obstet Gynecol 189 2003 S83
63. L. Detti, G. Mari, M. Akiyama, E. Cosmi, K.J. Moise, and T. Stefor Longitudinal assessment of the middle cerebral artery peak systolic velocity in healthy fetuses and in fetuses at risk for anemia Am J Obstet Gynecol 187 2002 937 939
64. L. Detti, U. Oz, I. Guney, J.E. Ferguson, R. Bahado-Singh, G. Mari For the Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization Am J Obstet Gynecol 185 2001 1048 1051
65. O. Deren, and L. Onderoglu The value of middle cerebral artery systolic velocity for initial and subsequent management in fetal anemia Eur J Obstet Gynecol Reprod Biol 101 2002 26 30
66. T. Stefos, E. Cosmi, L. Detti, and G. Mari Correction of fetal anemia on the middle cerebral artery peak systolic velocity Obstet Gynecol 99 2002 211 215
67. L. Detti, and G. Mari Noninvasive diagnosis of fetal anemia Clin Obstet Gynecol 46 2003 923 930
68. G. Mari, A. Abuhamad, J. Brumfield, and J.E. Ferguson II Doppler ultrasonography of the middle cerebral artery peak systolic velocity in the fetus: reproducibility of measurement Am J Obstet Gynecol 185 Suppl 2001 S261
69. L. Pereira, T.M. Jenkins, and V. Berghella Conventional management of maternal red cell alloimmunization compared with management by Doppler assessment of middle cerebral artery peak systolic velocity Am J Obstet Gynecol 189 2003 1002 1006
70. E.N. Nishie, M.L. Brizot, A.W. Liao, M.H.B. Carvalho, O. Toma, and M. Zugaib A comparison between middle cerebral artery peak systolic velocity and amniotic fluid optical density at 450 nm in the prediction of fetal anemia Am J Obstet Gynecol 188 2003 214 219
71. A. Ghidini, W. Sepulveda, C.J. Lockwood, and R. Romero Complications of fetal blood sampling Am J Obstet Gynecol 168 1993 1339 1344
72. B. Schumacher, and K.J. Moise Fetal transfusion for red blood cell alloimmunization in pregnancy Obstet Gynecol 88 1996 137 150
73. G. Giannina, K.J. Moise Jr, and K. Dorman A simple method to estimate the volume for fetal intravascular transfusion Fetal Diagn Ther 13 1998 94 97
74. K.H. Nicolaides, P.W. Soothill, W.H. Clewell, C.H. Rodeck, R.S. Mibashan, and S. Campbell Fetal haemoglobin measurement in the assessment of red cell isoimmunization Lancet 1 8594 1988 1073 1075
75. S.N. MacGregor, M.L. Socol, B.W. Pielet, J.T. Sholl, and J.P. Monogue Prediction of fetoplacental blood volume in isoimmunized pregnancy Am J Obstet Gynecol 159 1988 1493 1497
76. F. Forestier, F. Daffos, F. Galacteros, J. Bardakjian, M. Rainaut, and Y. Beuzard Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation Pediatr Res 20 1986 342 346
77. L. Hudson, K.J. Moise, S.E. Hegemier, R.M. Hill, A.A. Moise, and E.O. Smith Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease Am J Obstet Gynecol 179 1998 858 863
78. B. Schumacher, and K.J. Moise Fetal transfusion for red blood cell alloimmunization in pregnancy Obstet Gynecol 88 1996 137 150
79. G.R. Saade, K.J. Moise, M.A. Belfort, D.E. Hesketh, and R.J. Carpenter Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions Fetal Diagn Ther 8 1993 161 164